Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated Leukocytes

Clinical and Applied Thrombosis/Hemostasis

Volumn 6, Issue 4, 2000, Pages 213-221

  Nomura, Shosaku ^a   Okamae, Fumiko ^a   Abe, Misao ^a   Hosokawa, Mika ^a   Yamaoka, Manabu ^a   Ohtani, Tetsuji ^a   Onishi, Shuji ^a   Matsuzaki, Tatsunori ^a   Teraoka, Atsuko ^a   Ishida, Tomoko ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 6; P selectin glycoprotein ligand 1; Platelet concentrates; Platelet derived microparticle; Transfusion reaction

Indexed keywords

INTERLEUKIN 6; P SELECTIN GLYCOPROTEIN LIGAND 1; PLATELET DERIVED MICROPARTICLE; THROMBOCYTE CONCENTRATE; THROMBOCYTE FACTOR; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; BLOOD FILTRATION; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE TRANSFUSION; URTICARIA;

BLOOD PLATELETS; BLOOD PRESERVATION; CELL SEPARATION; ERYTHEMA; FEMALE; FEVER; FILTRATION; HUMANS; INTERLEUKIN-6; LEUKOCYTES; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; P-SELECTIN; PLATELET ACTIVATION; PLATELET TRANSFUSION; PROTEIN BINDING; URTICARIA;

EID: 0034541709     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960000600406     Document Type: Article

References (65)

1. Platelet transfusion therapy for the cancer patient
2. Febrile reactions after platelet transfusion: The effect of single versus multiple donors
3. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration
4. Increased tumor necrosis factor ct (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNFα and IL-6 levels and febrile transfusion reactions
5. Cytokine generation in stored platelet concentrates
6. The role of the plasma from platelet concentrates in transfusion reactions
7. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components
8. Febrile transfusion reactions reduced by use of buffy-coat-poor erythrocyte concentrates
9. Transfusion and host defenses against cancer recurrence and infection
10. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus
11. 2+-responsive operon fusion in Yersinia pestis
12. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood
13. The role of white cells in the transmission of Yersinia enterocolitica in blood components
14. Leukodepletion blood filters: Filter design and mechanisms of leukocyte removal
15. Electron-microscopic examination of white cell reduction by four white cell-reduction filters
16. Leukocyte depletion filters: A comparison of efficiency
17. Comparison of five different filters for the removal of leukocytes from red cell concentrates
18. Occurrence of the release reaction during preparation and storage of platelet concentrates
19. Platelet activation may explain the storage lesion in platelet concentrates
20. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage
21. The expression of P-selectin during collection, processing, and storage of platelet concentrates: Relationship to loss of in vivo viability
22. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane
23. Association of factor V activity with membranous vesicles released from human platelets: Requirement for platelet stimulation
24. Platelet-dericed microparticles express high affinity receptors for factor VIII
25. Vesiculation of platelets during in vitro aging
26. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells
27. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin
28. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1
29. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoitic cells
30. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
31. Differences between platelet and microparticle glycoprotein IIb/IIIa
32. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease
33. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus
34. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation
35. Leukocyte-poor platelet concentrates at the bedside by filteration through Sepacell-PL: Vox Sang
36. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry
37. syk activation by an anti-glycoprotein Ib monoclonal antibody
38. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage
39. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions
40. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components
41. Reactions to platelet transfusion: The effect of the storage time of the concentrate
42. Febrile reactions to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method Transfusion
43. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat
44. Cytokines, sepsis and immuno-modulation
45. The biology of interleukin-6
46. Platelet storage lesions in second generation containers: Correlation with in vivo behaviour with storage up to 14 days
47. In vivo platelet interactions in whole human blood exposed to biomaterial surfaces: Insights in blood compatibility
48. Detection of activated platelets in wole blood using activation-dependent monoclonal antibodies and flow cytometry
49. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets
50. Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53, 000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
51. Platelet membrane glycoproteins and microvesicles in blood from postoperative salvage: A study in cardiac bypass patients
52. Platelet procoagulant activity and microvesicle formation: Its putative role in hemostasis and thrombosis
53. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
54. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles
55. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of amminophospholipid translocase
56. Clinical significance of platelet microparticles in autoimmune thrombocytopenias
57. Plasma activity and complement activation during storage of citrated platelet concentrates
58. Isolated P-selectin glycoprotein ligand-1 dynamic adhesion to P- and E-selectin
59. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine surface motif of human PSGL-1 and blocks recognition of both P- and L-selectin
60. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-α-activated endothelium under flow in vitro
61. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter
62. Kinetics of bradykinin levels during and after leukocyte filtration of platelet concentrates
63. Platelet activation induced by interleukin-6: Evidence for a mechanism involving arachidonic acid metabolism
64. Morphologic and ultrastructual evidence for interleukin-6 induced platelet activation
65. Alteration of platelet function in dogs mediated by interleukin-6